Literature DB >> 30542744

Cartilage repair surgery prevents progression of knee degeneration.

Pia M Jungmann1,2, Alexandra S Gersing3, Frederic Baumann4, Christian Holwein5,6, Sepp Braun5,7, Jan Neumann8, Julia Zarnowski8, Felix C Hofmann8, Andreas B Imhoff5, Ernst J Rummeny3, Thomas M Link8.   

Abstract

PURPOSE: To investigate, whether cartilage repair surgery for focal osteochondral defects at the knee results in less degenerative changes over 6 years in a MR imaging follow-up than morphologically initially identical defects in non-operated control subjects from the osteoarthritis initiative (OAI).
METHODS: A total of 32 individuals received baseline and follow-up MRI. In n = 16 patients with cartilage repair [osteochondral autograft transfer system (OATS), n = 12; spongiosa-augmented matrix-associated autologous chondrocyte implantation (MACI), n = 4] MRI was performed preoperatively and after 5.7 ± 2.3 year follow-up. Baseline MRIs of non-operated subjects from the OAI were screened for initially identical cartilage defects (n = 16). Morphological knee abnormalities were assessed using WORMS, AMADEUS and MOCART scores. A sagittal 2D MSME sequence was implemented for quantitative cartilage T2 relaxation time measurements in all (0, 2, 4, 6 and 8-years) follow-ups from the OAI and in the postoperative MRI protocol.
RESULTS: For both groups, focal osteochondral defects were located at the femoral condyle in 8/16 cases (5 medial, 3 lateral) and at the patella in 8/16 cases. At baseline, the mean cartilage defect size ± SD was 1.4 ± 1.3 cm2 for the control group and 1.3 ± 1.2 cm2 for the cartilage repair group (n.s.). WORMS scores were not significantly different between the cartilage repair group and the control group at baseline [mean difference ± SEM (95%CI); 0.5 ± 2.5 (- 4.7, 5.7), n.s.]. During identical follow-up times, the progression of total WORMS scores [19.9 ± 2.3 (15.0, 24.9), P < 0.001] and of cartilage defects scores in the affected (P < 0.001) and in the opposing (P = 0.029) compartment was significantly more severe in non-operated individuals (P < 0.05). In non-operated subjects, T2 values increased continuously from baseline to the 8-year follow-up (P = 0.001).
CONCLUSIONS: Patients with cartilage repair showed less progression of degenerative MRI changes at 6-year follow-up than a control cohort from the OAI with initially identical osteochondral defects. Patients with focal cartilage defects may profit from cartilage repair surgery since it may prevent progression of early osteoarthritis at the knee joint. LEVEL OF EVIDENCE: Prognostic study, Level II.

Entities:  

Keywords:  Cartilage; Cartilage repair; Knee; MR imaging; Osteoarthritis; Osteochondral transplantation; Outcome

Mesh:

Year:  2018        PMID: 30542744     DOI: 10.1007/s00167-018-5321-8

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  15 in total

Review 1.  [Guidelines for the treatment of unicompartmental cartilage defects of the knee-Cartilage repair, osteotomy, mini-implant or arthroplasty?]

Authors:  Christoph Becher; Andreas Imhoff
Journal:  Orthopade       Date:  2020-12-18       Impact factor: 1.087

2.  Low postoperative complication rate with high survival rate and good clinical outcome 9 years after autologous chondrocyte transplantation of the knee joint.

Authors:  Yannick J Ehmann; Thekla Esser; Amr Seyam; Marco-Christopher Rupp; Julian Mehl; Sebastian Siebenlist; Andreas B Imhoff; Philipp Minzlaff
Journal:  Arch Orthop Trauma Surg       Date:  2022-10-05       Impact factor: 2.928

3.  Correlation between the quality of cartilage repair tissue and patellofemoral osteoarthritis after matrix-induced autologous chondrocyte implantation at three-year follow-up: a cross-sectional study.

Authors:  Jialing Lyu; Hongli Geng; Weimin Zhu; Dingfu Li; Kang Chen; Hui Ye; Jun Xia
Journal:  Int Orthop       Date:  2022-10-05       Impact factor: 3.479

4.  Patellofemoral cartilage defects are acceptable in patients undergoing high tibial osteotomy for medial osteoarthritis of the knee.

Authors:  Lisa Bode; Jan Kühle; Anna-Sophie Brenner; Viola Freigang; Helge Eberbach; Philipp Niemeyer; Norbert P Südkamp; Hagen Schmal; Gerrit Bode
Journal:  BMC Musculoskelet Disord       Date:  2022-05-24       Impact factor: 2.562

5.  Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes.

Authors:  Yuzhao Huang; Yuchen He; Meagan J Makarcyzk; Hang Lin
Journal:  Front Bioeng Biotechnol       Date:  2021-04-29

6.  Comparison of Clinical Outcome following Cartilage Repair for Patients with Underlying Varus Deformity with or without Additional High Tibial Osteotomy: A Propensity Score-Matched Study Based on the German Cartilage Registry (KnorpelRegister DGOU).

Authors:  Svea Faber; Peter Angele; Johannes Zellner; Gerrit Bode; Alfred Hochrein; Philipp Niemeyer
Journal:  Cartilage       Date:  2020-12-28       Impact factor: 3.117

7.  Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration.

Authors:  Pengfei Chen; Lin Zheng; Yiyun Wang; Min Tao; Ziang Xie; Chen Xia; Chenhui Gu; Jiaxin Chen; Pengcheng Qiu; Sheng Mei; Lei Ning; Yiling Shi; Chen Fang; Shunwu Fan; Xianfeng Lin
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

Review 8.  Autologous costal chondral transplantation and costa-derived chondrocyte implantation: emerging surgical techniques.

Authors:  Youshui Gao; Junjie Gao; Hengyuan Li; Dajiang Du; Dongxu Jin; Minghao Zheng; Changqing Zhang
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-09-23       Impact factor: 5.346

9.  Third-Generation Autologous Chondrocyte Implantation at the Knee Joint Using the Igor Scaffold: A Case Series With 2-Year Follow-up.

Authors:  Lukas Zak; Anne Kleiner; Christian Albrecht; Brigitte Tichy; Silke Aldrian
Journal:  Orthop J Sports Med       Date:  2021-01-22

10.  Safety and Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroids for Patellofemoral or Tibiofemoral Defects: A 5-Year Follow-up of a Phase 2, Dose-Confirmation Trial.

Authors:  Arnd Hoburg; Philipp Niemeyer; Volker Laute; Wolfgang Zinser; Thilo John; Christoph Becher; Kaywan Izadpanah; Peter Diehl; Thomas Kolombe; Jakob Fay; Rainer Siebold; Stefan Fickert
Journal:  Orthop J Sports Med       Date:  2022-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.